NASDAQ:APLT 17 November 2025 - 12 December 2025

Applied Therapeutics shares fell about 35% premarket to $0.14 after announcing a deal to be acquired by Cycle Pharmaceuticals. The offer includes $0.088 per share in cash and a non-transferable contingent value right tied to future FDA approvals and sales milestones. The transaction is expected to close in Q1 2026, pending a majority tender. No financing condition is attached to the merger.